The Leading Edge: Efzofitimod, the MostAdvanced Sarcoidosis InvestigationalTreatment

Learn about the most advanced sarcoidosis investigational treatment, efzofitimod. Gain an understanding of efzofitimod and its novel and differentiated mechanism of action. Plus, review the efzofitimod Ph1b/2a trial results, and hear about the EFZO-FIT Phase 3 trial design, including how to participate through the patient referral network program.
Email address contact: [e-mail]
Website: www.efzofit.com
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.